Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas

BACKGROUND: While the anti-PDGFRA antibody olaratumab failed to confirm an impact on survival in unselected advanced soft tissue sarcoma (STS) patients, the level of expression and the prognosis of platelet-derived growth factor (PDGF) receptors and ligands in STS remain unclear. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848659/
https://www.ncbi.nlm.nih.gov/pubmed/33524869
http://dx.doi.org/10.1016/j.esmoop.2020.100037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848659/
https://www.ncbi.nlm.nih.gov/pubmed/33524869
http://dx.doi.org/10.1016/j.esmoop.2020.100037

Ejemplares similares